Extreme price competition in pharmaceutical industry may put patients at serious health risk, study shows
Author: Shannon Roddel
New research from the University of Notre Dame, Indiana University and the University of Minnesota shows such competition-inducing regulations may encourage companies to relax quality standards during the manufacturing process, which may put more patients at serious health risk due to lower-quality products and more product recalls